SEC Form 4 · accession 0001125345-17-000012
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Thomas Jackson
Director
Period of report
Jan 24, 2017
Accepted (ET)
Jan 25, 2017 · 5:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $18.52 | Jan 24, 2017 | A | 20,000 | A | — | Jan 24, 2027 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The option will vest 1/12th of the shares monthly, beginning on the first monthly anniversary of the grant date and will become fully exercisable 1 year from the date of grant (1/24/18).